Literature DB >> 24858598

Pharmaceutical care for patients with COPD in Belgium and views on protocol implementation.

Eline Tommelein1, Kathleen Tollenaere, Els Mehuys, Koen Boussery.   

Abstract

BACKGROUND: A protocol-based pharmaceutical care program (the PHARMACOP-protocol) focusing on patient counselling during prescription filling has shown to be effective in patients with chronic obstructive pulmonary disease (COPD). However, implementation of this protocol in daily practice has not yet been studied.
OBJECTIVE: To describe current implementation level of the items included in the PHARMACOP-protocol in Belgian community pharmacies and to evaluate pharmacists' perspectives on the implementation of this protocol in daily practice.
METHOD: A cross-sectional study was conducted from April to June 2012, in randomly selected community pharmacies in Flanders. Pharmacists were questionned using structured interviews.
RESULTS: 125 pharmacies were contacted and 80 managing pharmacists (64 %) participated. In >70 % of pharmacies, 4/7 protocol items for first prescriptions and 3/5 protocol items for follow-up prescriptions were already routinely implemented. For first and follow-up prescriptions, respectively 39 (49 %) and 34 pharmacists (43 %) stated they would need to spend at least 5 min extra to offer optimal patient counselling. Most mentioned barriers preventing protocol implementation included lack of time (80 %), no integration in pharmacy software (61 %) and too much administrative burden (58 %).
CONCLUSION: Approximately 50 % of the PHARMACOP-protocol items are currently routinely provided in Belgian community pharmacies. Nearly all interviewed pharmacists are willing to implement the protocol fully or partially in daily practice.

Entities:  

Mesh:

Year:  2014        PMID: 24858598     DOI: 10.1007/s11096-014-9956-3

Source DB:  PubMed          Journal:  Int J Clin Pharm


  9 in total

1.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  J Clin Epidemiol       Date:  2008-04       Impact factor: 6.437

Review 2.  Educational programmes in COPD management interventions: a systematic review.

Authors:  Ana Stoilkova; Daisy J A Janssen; Emiel F M Wouters
Journal:  Respir Med       Date:  2013-09-04       Impact factor: 3.415

3.  ASHP guidelines on pharmacist-conducted patient education and counseling.

Authors: 
Journal:  Am J Health Syst Pharm       Date:  1997-02-15       Impact factor: 2.637

4.  Pharmaceutical care for people with depression: Belgian pharmacists' attitudes and perceived barriers.

Authors:  Sophie Liekens; Tim Smits; Gert Laekeman; Veerle Foulon
Journal:  Int J Clin Pharm       Date:  2012-04-03

5.  Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): a randomized controlled trial.

Authors:  Eline Tommelein; Els Mehuys; Thierry Van Hees; Els Adriaens; Luc Van Bortel; Thierry Christiaens; Inge Van Tongelen; Jean-Paul Remon; Koen Boussery; Guy Brusselle
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

6.  How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?

Authors:  F Gallefoss; P S Bakke
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

7.  Communication with patients who are dispensed a first prescription of chronic medication in the community pharmacy.

Authors:  Rolf van Hulten; Lyda Blom; Johan Mattheusens; Majanne Wolters; Marcel Bouvy
Journal:  Patient Educ Couns       Date:  2011-05-31

8.  A randomized controlled trial of a smoking cessation intervention based in community pharmacies.

Authors:  T A Maguire; J C McElnay; A Drummond
Journal:  Addiction       Date:  2001-02       Impact factor: 6.526

9.  White paper on expanding the role of pharmacists in chronic obstructive pulmonary disease: American Pharmacists Association Foundation.

Authors: 
Journal:  J Am Pharm Assoc (2003)       Date:  2011 Mar-Apr
  9 in total
  5 in total

Review 1.  Promoting Community Pharmacy Practice for Chronic Obstructive Pulmonary Disease (COPD) Management: A Systematic Review and Logic Model.

Authors:  Yuqi Hu; Dongning Yao; Carolina Oi Lam Ung; Hao Hu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-08-03

2.  Factors Affecting Community Pharmacist's Knowledge About Chronic Obstructive Pulmonary Disease (COPD) Management in China: A Cross-Sectional Survey Study.

Authors:  Yuqi Hu; Dongning Yao; Hao Hu; Carolina Oi Lam Ung
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-12-01

3.  The impact of pharmacist-managed clinic on medication adherence and health-related quality of life in patients with COPD: a randomized controlled study.

Authors:  Chuanwei Xin; Zhongni Xia; Cheng Jiang; Mengmeng Lin; Gonghua Li
Journal:  Patient Prefer Adherence       Date:  2016-07-11       Impact factor: 2.711

4.  Community pharmacists' knowledge of COPD, and practices and perceptions of medication counseling of COPD patients.

Authors:  Juha Markus Heikkilä; Stina Parkkamäki; Johanna Salimäki; Sari Westermarck; Marika Pohjanoksa-Mäntylä
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-07-03

5.  Knowledge, Attitude and Practice of Lebanese Community Pharmacists toward Chronic Obstructive Pulmonary Disease.

Authors:  Souheil Hallit; Rouba Karen Zeidan; Sylvia Saade; Aline Hajj; Rabih Hallit; Marwan Akel; Charbel Yahchouchy; Nelly Kheir; Katia Iskandar; Hala Sacre; Pascale Salameh
Journal:  J Epidemiol Glob Health       Date:  2020-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.